Listar Artículos ADMIRABLE por título
Mostrando ítems 80-99 de 146
-
Network analysis of co-participation in thesis examination committees in an academic field in Spain
(2023-04, Asociación para el Desarrollo de la Ingeniería de Organización (ADINDOR))Artículo -
Neurological Disorders in Central Spain, Second Survey: Feasibility Pilot Observational Study
(2019-01, JMIR Publications)Artículo -
A New Measure for Serious Games Evaluation: Gaming Educational Balanced (GEB) Model
(2022-11, MDPI)Artículo -
New strategy for the optimal design and manufacture of high performance milling heads
(2011-11, Consejo Superior de Investigaciones Científicas)Artículo -
Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort
(2020-10, Springer Nature)Artículo -
Nonlinear physics opens a new paradigm for accurate transcription start site prediction
(2022-12, Springer Nature)Artículo -
Observation of Metacognitive Skills in Natural Environments: A Longitudinal Study With Mixed Methods
(2019-11, Frontiers Media)Artículo -
Occupational performance in Huntington’s disease: A cross-sectional study
(2023-04, SAGE Publications)Artículo -
Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
(2022-04, IOS Press)Artículo -
Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis
(2015-12, Public Library of Science)Artículo -
Parkinson’s Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline
(2017-10, Frontiers Media)Artículo -
Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
(2021-11, Springer Nature)Artículo -
Perceived satisfaction of university students with the use of chatbots as a tool for self-regulated learning
(2023-01, Cell Press)Artículo -
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
(2023-02, MDPI)Artículo -
Pharmacotherapy in the management of early Parkinson’s disease: cost-effectiveness and patient acceptability
(2010-09, Taylor & Francis Group)Artículo -
Posibilidades de la realidad virtual en la reducción de accidentes laborales en la Industria 4.0
(2021-11, Publicaciones DYNA)Artículo -
Predictors of clinically significant quality of life impairment in Parkinson’s disease
(2021-12, Springer Nature)Artículo